Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Huntsman

Showing results (81-90 of 320) with videos related to

Pageof 32
Sort By:
Scientific Reports|January 19, 2025
Quantifying intratumoral biomarker heterogeneity in tubo-ovarian high-grade serous carcinoma to optimize clinical translationAline Talhouk, Derek S Chiu, Liliane Meunier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2007
A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosisJacques Lapointe, Young H Kim, Melinda A Miller, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 26, 2013
FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelinesStefan Kommoss, Michael S Anglesio, Robertson Mackenzie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 21, 2010
P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancerGulisa Turashvili, Steven E McKinney, Ozge Goktepe, et al.
Genes, Chromosomes & Cancer|December 21, 2004
beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancerGianpaolo Suriano, Nikoleta Vrcelj, Janine Senz, et al.
Histopathology|September 17, 2013
Accelerating type-specific ovarian carcinoma research: Calculator for Ovarian Subtype Prediction (COSP) is a reliable high-throughput tool for case reviewStefan Kommoss, Cyril Blake Gilks, Friedrich Kommoss, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 22, 2010
De novo expression of CD44 variants in sporadic and hereditary gastric cancerCristiana Branco da Cunha, Carla Oliveira, Xiaogang Wen, et al.
Annals of Surgery|May 25, 2007
CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancerJeffrey A Norton, Christine M Ham, Jacques Van Dam, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 7, 2016
BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian CancerJohn P Stamp, C Blake Gilks, Martine Wesseling, et al.
Breast Cancer Research and Treatment|January 26, 2010
Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypesYesim Gökmen-Polar, Rutika Mehta, Sukru Tuzmen, et al.
Pageof 32

Showing results (81-90 of 320) with videos related to

Sort By:
Pageof 32
Scientific Reports|January 19, 2025
Quantifying intratumoral biomarker heterogeneity in tubo-ovarian high-grade serous carcinoma to optimize clinical translationAline Talhouk, Derek S Chiu, Liliane Meunier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2007
A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosisJacques Lapointe, Young H Kim, Melinda A Miller, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 26, 2013
FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelinesStefan Kommoss, Michael S Anglesio, Robertson Mackenzie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 21, 2010
P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancerGulisa Turashvili, Steven E McKinney, Ozge Goktepe, et al.
Genes, Chromosomes & Cancer|December 21, 2004
beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancerGianpaolo Suriano, Nikoleta Vrcelj, Janine Senz, et al.
Histopathology|September 17, 2013
Accelerating type-specific ovarian carcinoma research: Calculator for Ovarian Subtype Prediction (COSP) is a reliable high-throughput tool for case reviewStefan Kommoss, Cyril Blake Gilks, Friedrich Kommoss, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 22, 2010
De novo expression of CD44 variants in sporadic and hereditary gastric cancerCristiana Branco da Cunha, Carla Oliveira, Xiaogang Wen, et al.
Annals of Surgery|May 25, 2007
CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancerJeffrey A Norton, Christine M Ham, Jacques Van Dam, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 7, 2016
BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian CancerJohn P Stamp, C Blake Gilks, Martine Wesseling, et al.
Breast Cancer Research and Treatment|January 26, 2010
Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypesYesim Gökmen-Polar, Rutika Mehta, Sukru Tuzmen, et al.
Pageof 32